BAFIARS - Biomedical Assessment of Function and Imaging of the Ano-rectal Sphincter

Sponsor
University Hospital Inselspital, Berne (Other)
Overall Status
Suspended
CT.gov ID
NCT02778048
Collaborator
Nano-Tera.ch, Lausanne (Other), Kantonsspital Winterthur KSW (Other), University of Bern (Other), University of Basel (Other)
50
1
17.1
2.9

Study Details

Study Description

Brief Summary

With the project Smart Muscle for Incontinence Treatment (SMIT) a multidisciplinary consortium consisting of representatives ranging from clinical medicine via microelectronics towards biomaterial science aims to develop a novel implant to treat faecal incontinence. The aim of this campaign includes development of implantable prototype devices acting as artificial continence muscles using low-voltage electrically activated polymers (EAPs) controlled by implemented pressure sensors and the patient.

Subsequently, the knowledge of the anatomical and biomechanical properties of the anal sphincter complex are of cardinal importance. Most of the existing data on anatomy and physiology results is based on old studies and almost no data on biomechanical properties are available. However, new technologies or even merging data from different examination methods might provide new information in this field.

Condition or Disease Intervention/Treatment Phase
  • Other: MRI (magnetic resonance imaging)
  • Other: US (ultra sound)
  • Other: FLIP (functional lumen imaging probe)
  • Other: HRAM (high resolution anal manometry)

Detailed Description

Background Fecal incontinence (FI) is affecting self-confidence and can lead to social isolation and even loss of employment Often conservative treatment as the first option is ineffective and surgical interventions follow conservative are necessary. Small defects of the anal sphincter muscles might be treated with sphincter repair and sacral neuromodulation (SNM) However, patients rarely become fully continent or short-term results deteriorate in the long term. Those patients and patients with large defects are candidates for a neosphincter procedure (artificial bowel sphincter or graciloplasty). However, the success rate of these methods is limited and the explantation rate is high. A permanent colostomy associated with massive psychosocial impairment remains as ultimate treatment option With the project Smart Muscle for Incontinence Treatment (SMIT) a multidisciplinary consortium consisting of representatives ranging from clinical medicine via microelectronics towards biomaterial science aims to develop a novel implant to treat faecal incontinence. The aim of this campaign includes development of implantable prototype devices acting as artificial continence muscles using low-voltage electrically activated polymers (EAPs) controlled by implemented pressure sensors and the patient. Subsequently, the knowledge of the anatomical and biomechanical properties of the anal sphincter complex are of cardinal importance. Most of the existing data on anatomy and physiology results is based on old studies and almost no data on biomechanical properties are available. However, new technologies or even merging data from different examination methods might provide new information in this field. Accurate imaging data on the pelvic floor region is crucial for the development of a new, implantable device for restoration of fecal continence. Optimal size (inner, outer diameter, length) and geometrical shape (cylinder, cone, torus) adapted to different functional states (rest, squeezing, defecation) will improve function and prevent erosion and consequent infection of such a prosthesis. With this study, the investigators aim to correlate three-dimensional endoanal ultrasonographic images with MRI images. The combination of different imaging techniques has been demonstrated to eliminate individual drawbacks of the examination methods and therefore would allow a precise description of the tissue. The registered data with their complementary information would permit the distinct segmentation and three-dimensional presentations of the anatomical structures in the pelvic area. This information has a great potential to facilitate diagnostics and surgical planning in this region. High-resolution anal manometry (HRAM) provides intra-anal pressure during rest or maximum pressure with high spatial and time resolution. However Biomechanical properties of the anal canal as elasticity or stiffness (compliance or flexibility) of the tissue representing important parameters for a continence organ are not routinely evaluated in daily clinical practice. Functional Lumen Imaging Probe (FLIP) allows the measurement of a cross sectional area (CSA) with respect to applied luminal pressure, respectively. FLIP has the potential to be useful in order to assess the biomechanical properties of the sphincter region. Such information potentially gives new insights in physiology and pathophysiology of the continence process. With this pilot study, the investigators aim to acquire anatomical and biomechanical data using established (manometry) and novel technologies (merging endoanal ultrasound and MRI data) in 50 patients suffering from Fecal Incontinence.

Objective Primary objective is to collect anatomical, physiological and biomechanical characteristics of the continence organ (sphincters and pelvic floor) in patients suffering from fecal incontinence and to compare this data with data gathered in an earlier study (NCT02263170) on healthy volunteers.

Secondary objectives are: test feasibility of FLIP in measuring the biomechanical properties of the anal canal and test feasibility of merging 3D US data and MR images.

Methods For the assessment of the morphology ultra sound and MRI will be used, whereas FLIP (functional luminance imaging probe) and HRAM (high resolution anal manometry) are the modality of choice to investigate the biomechanical properties of the sphincter complex.

Study Design

Study Type:
Observational
Anticipated Enrollment :
50 participants
Observational Model:
Other
Time Perspective:
Retrospective
Official Title:
Assessment of Anatomic, Physiologic and Biomechanical Characteristics of the Anal Canal and Pelvic Floor - An Observational Single Center Study on Patients Suffering From Fecal Incontinence.
Anticipated Study Start Date :
Jul 1, 2019
Anticipated Primary Completion Date :
Dec 1, 2020
Anticipated Study Completion Date :
Dec 1, 2020

Arms and Interventions

Arm Intervention/Treatment
fecal incontinence patients (m/f)

patients suffering from fecal incontinence (m/f) are going to be assessed via MRI, US, FLIP, and HRAM

Other: MRI (magnetic resonance imaging)
Assessment of the sphincter

Other: US (ultra sound)
Assessment of the sphincter

Other: FLIP (functional lumen imaging probe)
Assessment of the sphincter

Other: HRAM (high resolution anal manometry)
Assessment of the sphincter

Outcome Measures

Primary Outcome Measures

  1. sphincter closing pressure [mmHG] [1 year]

    at rest and during squeeze manoeuvres

  2. sphincter muscle length [mm] [1 year]

  3. sphincter muscle thickness [mm] [1 year]

  4. sphincter compliance [mm/mmHG] [1 year]

    The compliance is a measure used in medicine describing the elasticity of tissue. In the case of this study it describes the elasticity of the anal canal, the sphincter muscles respectively. The compliance is directly measured with the help of the functional lumen imaging probe (FLIP).

Secondary Outcome Measures

  1. Young's modulus of sphincter muscle (mmHG/mm2] [1 year]

    combination of compliance and anatomical properties

Eligibility Criteria

Criteria

Ages Eligible for Study:
60 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Informed Consent as documented by signature

  • Wexner score >= 12

  • Longo's obstructed defecation syndrome (ODS) score =0

  • MRI safety (no metallic implants. Appendix MRI safety form)

  • Normal weighted (20<BMI<30)

  • Age ≥ 60 years

Exclusion Criteria:
  • Other clinically significant concomitant disease states (e.g., renal failure, hepatic dysfunction, cardiovascular disease, etc.)

  • Known or suspected non-compliance, drug or alcohol abuse

  • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Hospital Bern Bern Switzerland 3010

Sponsors and Collaborators

  • University Hospital Inselspital, Berne
  • Nano-Tera.ch, Lausanne
  • Kantonsspital Winterthur KSW
  • University of Bern
  • University of Basel

Investigators

  • Principal Investigator: Lukas Brügger, PD, Dr. med., University of Bern

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital Inselspital, Berne
ClinicalTrials.gov Identifier:
NCT02778048
Other Study ID Numbers:
  • KEK BE 359/15
First Posted:
May 19, 2016
Last Update Posted:
Jan 16, 2019
Last Verified:
Jan 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 16, 2019